Why Your Wegovy Dosing Chart Choice Matters: The Science
Wegovy vs Mounjaro Dosing Chart: Key Differences Explained
The Wegovy dosing chart follows a structured 5-step escalation over 16 weeks, starting at 0.25mg and reaching 2.4mg maintenance dose. This contrasts significantly with Mounjaro's 6-dose schedule spanning 2.5mg to 15mg maximum. Understanding your wegovy dosing chart progression helps set realistic expectations for your weight management journey. Each treatment requires mandatory dose escalation - you cannot skip steps or start at higher doses regardless of previous experience with weight management medications.
The fundamental difference lies in their mechanisms: Wegovy targets GLP-1 receptors exclusively, while Mounjaro activates both GIP and GLP-1 pathways simultaneously. This dual-action approach means Mounjaro's dosing chart reflects higher absolute numbers, but both medications require careful titration to minimise gastrointestinal side effects. Your prescriber will determine which wegovy dosing chart approach suits your individual medical profile and weight management goals best.
Complete UK Pricing Comparison: Wegovy Dosing Chart Costs
EverydayMeds offers transparent pricing across the entire Wegovy dosing chart journey: 0.25mg starter dose costs £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for maintenance 2.4mg pens. New customers apply code FIRST40 at checkout to reach these final prices, while returning customers use DOSE25. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) provide convenient two-pen supplies for £169.99. The wegovy dosing chart escalation means most patients require different strengths monthly, making our step-up bundles particularly valuable for seamless progression.
Mounjaro pricing follows a different structure reflecting its unique dosing requirements, with both treatments available through our streamlined ordering process. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring consistent access once you've completed the wegovy dosing chart escalation. Bundle pricing emphasises convenience rather than savings - fewer orders, Reliable Supply continuity, and single temperature-controlled deliveries reduce treatment interruption risks during your dosing journey.
Clinical Evidence Behind Wegovy Dosing Chart Design
The wegovy dosing chart structure derives from extensive STEP trial programmes, particularly STEP 1 which demonstrated approximately 15% average weight loss at 68 weeks versus 2.4% with placebo. Wilding et al., NEJM, 2021, established this escalation protocol to optimise therapeutic benefits while minimising dose-dependent side effects. The 4-week intervals between dose increases allow your body to adapt to each strength before progression.
STEP 5 trial data confirmed sustained benefits following the complete wegovy dosing chart protocol, with patients maintaining approximately 15.2% weight reduction at two years. The SELECT cardiovascular outcomes study revealed 20% reduction in major cardiovascular events (HR 0.80), validating the clinical importance of completing the full dosing schedule. These trials consistently used the same wegovy dosing chart escalation we follow at EverydayMeds, ensuring evidence-based treatment protocols.
How Wegovy's Mechanism Influences Your Dosing Chart
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. The wegovy dosing chart gradual escalation allows these appetite-regulating effects to develop progressively, reducing the likelihood of severe nausea or gastrointestinal discomfort. Unlike Mounjaro's dual-hormone approach, Wegovy's single-pathway mechanism requires specific dose titration to achieve optimal GLP-1 receptor activation. The medication works primarily on brain appetite centres, potentially reducing food cravings as you progress through each wegovy dosing chart stage. This targeted mechanism explains why the dosing schedule cannot be accelerated - your GLP-1 receptors need time to adapt to increasing semaglutide concentrations for sustained therapeutic effect.
Streamlined Ordering Process for Your Wegovy Dosing Chart Journey
Beginning your wegovy dosing chart progression starts with our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (24-hour express service available), ensuring clinical appropriateness before dispensing any wegovy dosing chart strength. Once approved, next-day delivery arrives via temperature-controlled cold-chain transport, maintaining medication integrity throughout the UK. Our GPhC-registered pharmacy (#9012878) handles all dispensing and delivery logistics, allowing you to focus on your treatment journey. The assessment covers your entire intended wegovy dosing chart progression, enabling seamless prescription updates as you advance through each strength without repeated consultations.
Storage and Practical Considerations for Wegovy Dosing Chart Success
Wegovy pens require refrigeration at 2-8°C before first use, but offer exceptional convenience with 6 weeks room temperature storage once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with busy lifestyles. Each FlexTouch pen delivers precise doses according to your wegovy dosing chart stage, with clear numerical displays preventing dosing errors. The once-weekly injection schedule means each pen provides 4 weeks of treatment, aligning perfectly with the monthly dose escalations throughout your wegovy dosing chart progression. Store unused pens in original packaging to protect from light, and never freeze or shake the medication as this affects its therapeutic efficacy.
Wegovy Dosing Chart vs Mounjaro: Storage and Administration Differences
The wegovy dosing chart benefits from superior storage flexibility, maintaining stability for 6 weeks at room temperature compared to Mounjaro's 21-day limit. This practical advantage proves crucial during holidays, business travel, or power outages affecting refrigeration. Both medications require weekly injections, but their dose escalation patterns differ significantly - Wegovy's 5-step wegovy dosing chart versus Mounjaro's 6-step progression to higher absolute doses. The injection volumes remain consistent throughout your wegovy dosing chart journey, while Mounjaro's dual-hormone formulation requires different injection considerations.
FlexTouch pen technology in Wegovy provides tactile and audible feedback during injection, ensuring accurate dose delivery throughout your wegovy dosing chart progression. The pen's dose counter clearly displays your prescribed strength, preventing confusion as you advance through the escalation schedule. Both treatments require prescription-only medicine protocols, but Wegovy's established wegovy dosing chart allows for more predictable progression planning and supply management through our bundle options.
Making Your Choice: Complete Wegovy Dosing Chart Access at EverydayMeds
Both Wegovy and Mounjaro represent excellent weight management options available through our comprehensive service, with your prescriber determining the most suitable wegovy dosing chart approach based on your individual circumstances. Our clinical team supports patients throughout their chosen dosing journey, whether following Wegovy's 5-step escalation or Mounjaro's alternative protocol. Use code FIRST40 for new customer pricing, or DOSE25 for returning patients, with all wegovy dosing chart strengths available for next-day delivery. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and access both treatment options through our GPhC-registered pharmacy (#9012878). Our streamlined process ensures you receive expert clinical oversight alongside the convenience of home delivery, supporting your weight management success throughout your chosen wegovy dosing chart progression.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
